Skip to main content
. Author manuscript; available in PMC: 2016 May 14.
Published in final edited form as: Nanoscale. 2015 May 14;7(18):8378–8388. doi: 10.1039/c4nr07139e

Figure 7.

Figure 7

Selectivity and specificity of PEG-FOL-Cu2S-DOX towards cancer cells. a) In vitro selective tumoricidal activity of PEG-FOL-Cu2S-DOX at different concentrations (0.01 – 1mg/mL) in comparison to free DOX post 24 h incubation with cells. b) Cancer specific cellular entry of PEG-FOL-Cu2S-DOX NCs. The specificity of NC entry only into cancer cell (Gl-1) could be attributed to the folate targeting.